Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors (Q36690209)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 March 2013
edit
Language Label Description Also known as
English
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
scientific article published on 8 March 2013

    Statements

    Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors (English)
    Claudia Marcela Diaz
    Alberto Chiappori
    Luigi Aurisicchio
    Jesus C Fabregas
    Elisa Scarselli
    Nicola La Monica
    Gennaro Ciliberto
    Alberto J Montero

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit